PPA
NVO

Pacific Point Advisors’s Novo Nordisk NVO Stock Holding History

Pacific Point Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,248
Closed -$1.01M – 139
2025
Q3 		$1.01M Buy
18,248
+646
+4% +$37.8K 0.59% 59
2025
Q2 		$1.21M Buy
17,602
+1,191
+7% +$81K 0.66% 45
2025
Q1 		$1.14M Buy
16,411
+1,076
+7% +$88.9K 0.63% 44
2024
Q4 		$1.27M Buy
+15,335
New +$1.66M 0.77% 38

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Pacific Point Advisors's NVO Position: Q4 2025 in Review

Pacific Point Advisors sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 18,248 shares — an estimated $1.01M sold.

Pacific Point Advisors first reported a position in NVO in Q4 2024 and held it in 4 quarters. The position peaked at $1.27M in Q4 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Pacific Point Advisors reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Pacific Point Advisors sold 18,248 Novo Nordisk shares in Q4 2025, an estimated $1.01M.
  • Pacific Point Advisors first reported a position in Novo Nordisk in Q4 2024 and held it in 4 quarters.
  • Pacific Point Advisors's Novo Nordisk position peaked at $1.27M in Q4 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Pacific Point Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.